Form 8-K - Current report:
SEC Accession No. 0001564590-20-056245
Filing Date
2020-12-07
Accepted
2020-12-07 08:15:20
Documents
12
Period of Report
2020-12-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K onct-8k_20201207.htm   iXBRL 8-K 55392
  Complete submission text file 0001564590-20-056245.txt   188700

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA onct-20201207.xsd EX-101.SCH 5780
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE onct-20201207_lab.xml EX-101.LAB 19466
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE onct-20201207_pre.xml EX-101.PRE 11635
5 EXTRACTED XBRL INSTANCE DOCUMENT onct-8k_20201207_htm.xml XML 3570
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

EIN.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 201371412
SIC: 2834 Pharmaceutical Preparations